Abstract | AIM: METHODS:
Elcatonin was administrated at a dose of 20 units once weekly for 3 months. The visual analog scale (VAS) and the frequency scale for the symptoms of GERD (FSSG) were used to evaluate lower back pain and GERD symptoms, respectively. RESULTS: Both VAS and FSSG scores significantly decreased after 1, 2 and 3 months of elcatonin administration (at least P < 0.001). Even after the cessation of elcatonin, both scores remained significantly low for an extra 1 and 3 months, respectively. These beneficial effects were also observed in non-steroidal anti-inflammatory drug ( NSAID) or GERD drug users. CONCLUSION:
|
Authors | Yuko Yamane, Toru Yamaguchi, Michihiro Tsumori, Mika Yamauchi, Shozo Yano, Masahiro Yamamoto, Chie Honda, Yoshikazu Kinoshita, Toshitsugu Sugimoto |
Journal | Geriatrics & gerontology international
(Geriatr Gerontol Int)
Vol. 11
Issue 2
Pg. 215-20
(Apr 2011)
ISSN: 1447-0594 [Electronic] Japan |
PMID | 21199237
(Publication Type: Journal Article)
|
Copyright | © 2011 Japan Geriatrics Society. |
Chemical References |
- Bone Density Conservation Agents
- Calcitonin
- elcatonin
|
Topics |
- Aged
- Aged, 80 and over
- Bone Density Conservation Agents
(administration & dosage)
- Calcitonin
(administration & dosage, analogs & derivatives)
- Female
- Gastroesophageal Reflux
(drug therapy, etiology)
- Humans
- Kyphosis
(complications)
- Low Back Pain
(drug therapy, etiology)
- Male
- Osteoporosis
(complications)
- Treatment Outcome
|